Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001477845-17-000001
Filing Date
2017-12-22
Accepted
2017-12-22 10:05:07
Documents
1
Effectiveness Date
2017-12-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8314
  Complete submission text file 0001477845-17-000001.txt   9341
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
QR Pharma, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-301506 | Film No.: 171271471